Elevated endothelial progenitor cells during painful sickle cell crisis

Experimental Hematology

Volumn 37, Issue 9, 2009, Pages 1054-1059

  van Beem, Rachel T ^a   Nur, Erfan ^b,c,d   Zwaginga, Jaap Jan ^a,e   Landburg, Precious P ^d,f   van Beers, Eduard J ^b,c,d   Duits, Ashley J ^d,f   Brandjes, Dees P ^b,d   Lommerse, Ingrid ^a   de Boer, Hetty C ^e   van der Schoot, C Ellen ^a   Schnog, John John B ^d   Biemond, Bart J ^c,d  

^a SANQUIN RESEARCH   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d The CURAMA Study Group   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Red Cross Blood Bank Foundation   (Netherlands Antilles)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; ERYTHROPOIETIN; INTERLEUKIN 8; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE CHEST SYNDROME; ADULT; ANGIOGENESIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; ISCHEMIA; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETINOPATHY; SICKLE CELL CRISIS; STEM CELL; STEM CELL MOBILIZATION;

ADULT; ANEMIA, SICKLE CELL; ENDOTHELIAL CELLS; ERYTHROPOIETIN; FEMALE; HUMANS; INTERLEUKIN-8; ISCHEMIA; LEUKOCYTE COUNT; MALE; NEOVASCULARIZATION, PATHOLOGIC; PAIN; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68749121076     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.06.003     Document Type: Article

References (30)

1. Frenette P.S., and Atweh G.F. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 117 (2007) 850-858
2. Jeney V., Balla J., Yachie A., et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100 (2002) 879-887
3. Duits A.J., Rodriguez T., and Schnog J.J. Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease. Br J Haematol 134 (2006) 116-119
4. Mohan J.S., Lip P.L., Blann A.D., Bareford D., and Lip G.Y. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Br J Ophthalmol 89 (2005) 815-819
5. Moritani T., Numaguchi Y., Lemer N.B., et al. Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography. Clin Imaging 28 (2004) 173-186
6. Kato G.J., Hsieh M., Machado R., et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol 81 (2006) 503-510
7. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
8. Van Craenenbroeck E.M., Conraads V.M., Van Bockstaele D.R., et al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J Immunol Methods 20 332 (2008) 31-40
9. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
10. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
11. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
12. Duits A.J., Rojer R.A., van Endt T., et al. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Ann Hematol 82 (2003) 171-174
13. Duits A.J., Schnog J.B., Lard L.R., Saleh A.W., and Rojer R.A. Elevated IL-8 levels during sickle cell crisis. Eur J Haematol 61 (1998) 302-305
14. Serjeant G.R., Ceulaer C.D., Lethbridge R., Morris J., Singhal A., and Thomas P.W. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol 87 (1994) 586-591
15. Nevskaya T., Bykovskaia S., Lyssuk E., et al. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations. Clin Exp Rheumatol 26 (2008) 421-429
16. Powars D.R., Hiti A., Ramicone E., Johnson C., and Chan L. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol 70 (2002) 206-215
17. Cao J., Mathews M.K., McLeod D.S., Merges C., Hjelmeland L.M., and Lutty G.A. Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol 83 (1999) 838-846
18. Kato G.J., Gladwin M.T., and Steinberg M.H. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21 (2007) 37-47
19. Schnog J.J., Lard L.R., Rojer R.A., van der Dijs F.P., Muskiet F.A., and Duits A.J. New concepts in assessing sickle cell disease severity. Am J Hematol 58 (1998) 61-66
20. Hebbel R.P., Eaton J.W., Balasingam M., and Steinberg M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70 (1982) 1253-1259
21. Nath K.A., Grande J.P., Croatt A.J., et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 166 (2005) 963-972
22. Aicher A., Zeiher A.M., and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45 (2005) 321-325
23. Kaul D.K., and Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106 (2000) 411-420
24. Bahlmann F.H., DeGroot K., Duckert T., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64 (2003) 1648-1652
25. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (2004) 858-864
26. Gallagher K.A., Liu Z.J., Xiao M., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117 (2007) 1249-1259
27. Goldstein L.J., Gallagher K.A., Bauer S.M., et al. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24 (2006) 2309-2318
28. Yang Z., Wang J.M., Chen L., Luo C.F., Tang A.L., and Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens 21 (2007) 452-460
29. Heiss C., Wong M.L., Block V.I., et al. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol 215 (2008) 366-373
30. Wood K.C., Hsu L.L., and Gladwin M.T. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med 44 (2008) 1506-1528